Local Anesthesia Drugs Market by Drugs Type (Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Prilocaine, Benzocaine, and Other Local Anesthetics), Application (Injectable and Surface Anesthetic), and Regional Analysis (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031

Global Local Anesthesia Drugs Market Analysis

The Global Local Anesthesia Drugs Market Size was $2,643.50 million in 2021 and is predicted to grow with a CAGR of 6.4%, by generating a revenue of $4,724.80 million by 2031.

Global Local Anesthesia Drugs Market Synopsis

The growing incidences of chronic diseases among people and rising hospitalization rate globally has triggered the growth of local anesthesia drugs market share growth in the forecast time. Chronic diseases like cancer and tumors require intense treatment which can cause intense pain in the patients’ body, thereby making then traumatic during treatment or surgical procedures. Local anesthesia helps in making the affected area numb so that the surgical procedure can be conducted smoothly and the patient is able to bear the pain. This factor is likely to drive the local anesthesia market share growth in the forecast time period.

The market growth is expected to be restricted in the forecast period owing to side effects caused by the anesthesia. Also, strict regulations imposed on the use of anesthesia drugs by the regulatory bodies is likely to impede local anesthesia drugs market growth in the forecast time period.

The introduction of novel and effective medications such as articaine and ropivacaine is further fueling the expansion of the market for local anesthesia drugs. This expansion is augmented by rising healthcare spending in developing countries such as India, China, and Brazil, where the number of surgeries performed has been steadily increasing.

Region-wise, the North America local anesthesia drugs market accounted for a dominating market share in 2021.

Local Anesthesia Drugs Overview

Local anesthesia is a temporary loss of sensation in a specific place or parts of the body. Local anesthesia drugs are used to treat uncomfortable circumstances, eliminate pain when performing large or minor surgeries, and reduce pain after surgery. At greater doses, certain drugs are utilized as local anesthetics. A local anesthetic can be administered directly into the affected area or absorbed through the skin. When a vast area needs to be anaesthetized or medications may not penetrate sufficiently, the doctor may use a different anesthetic that lasts 4 to 6 hours.

COVID-19 Impact on Global Local Anesthesia Drugs Market

The COVID-19 pandemic has had a moderate impact on the local anesthesia drugs industry. Several swift alterations in reaction to COVID-19 had an immediate impact on local anesthetic medicines and their practices. Because of the lockdown, the supply chain for anesthesia drugs, globally, was slowed. The most difficult consequences resulted from the cancellation or postponing of non-essential surgical operations, which had a direct negative impact on the demand of anesthesia drugs. Anesthetics may reduce the effectiveness of a COVID-19 vaccination. This is due to the fact that a vaccine interacts with the immune system, as does anesthesia, both of which can interfere with how a vaccine teaches the body to fight infection. The American Society of Anesthesiologists recommends waiting at least two weeks following the last dose before undergoing anesthetic-assisted surgery.

However, the demand for local anesthesia was high owing to increased cases of viral infection and the high severity of symptoms observed in the patients. As the hospitalization rates increased in the pandemic era, the demand for anesthetic drugs also increased which has moderately impacted the market growth.

Growing Number of Surgical Procedures Globally Projected to Drive Market Growth

Rising cases of chronic diseases, like cancer and diabetes and high hospitalization rates due to these diseases, globally, is projected to drive the global local anesthesia market share growth in the forecast time period. Patients suffering from cancer, for instance, require hospitalizations, surgery, chemotherapy, anesthetic, and pain medication. Analgesia is routinely treated with opioids and local anesthetics. Also, rising incidences of surgeries, globally, owing to complications due to old age, accidents and dental treatments is expected to increase the demand for local anesthesia drugs. The growth in the number of surgeries performed can be attributed to the ageing population, which is more prone to chronic diseases such as cardiovascular disorders, respiratory ailments, cancer, neurological disorders, and various gastro, orthopedic, and spinal difficulties. For instance, according to a research paper ‘Trauma of major surgery: A global problem that is not going away’, published in September, 2022, worldwide, approximately 310 million major surgeries are performed every year out of which nearly 40 to 50 million surgeries take place in USA and 20 million in Europe. This factor is likely to drive the local anesthesia market in the forecast time period.

To know more about global local anesthesia drugs market drivers, get in touch with our analysts here.

Various Side Effects Associated with Using Local Anesthesia to Restrain Market Growth

Although, using local anesthesia is much better that using intravenous anesthesia, several side effects are also associated with it. Pain after injection, needle fracture, edema, anesthetic prolongation and numerous temporal abnormalities, trismus, inflammation, hematoma, skin injury, gingival lesions, and ocular complications are some common consequences that may limit market growth. Also, adoption of non-invasive surgeries that do not require the use of local anesthesia by patients and healthcare professionals is further  likely to hinder local anesthesia drugs market revenue growth in the forecast time period.

New Anesthetic Drug Launches By the Manufacturers to Drive the Market Growth

The introduction of novel and effective medications such as articaine, and ropivacaine is further fueling the expansion of the market for local anesthesia drugs. For instance, according to a news published by American Hospital Association, on September 18, 2020, the Food and Drug Administration approved a new intravenous general anesthetic drug for propofol injectable emulsion. Also, increased reimbursement policies by the government and insurers for covering expensive surgeries has increased the number of patients opting for surgeries for various chronic diseases. This factor is further anticipated to drive market growth in the future. Also, the market expansion is augmented by rising healthcare spending in developing countries such as India, and Brazil, where the number of surgeries performed has been steadily increasing.

To know more about global local anesthesia drugs market opportunities, get in touch with our analysts here.

Global Local Anesthesia Drugs Market, By Drug Type

By drugs type, the market has been divided into bupivacaine, ropivacaine, lidocaine, chloroprocaine, prilocaine, benzocaine and other local anesthetics. Among these, the Lidocaine segment had a dominant market share in 2021 and Bupivacaine is anticipated to have the fastest growth in the forecast time period.

Global Local Anesthesia Drugs Market Size, by Drugs Type, 2021

Source: Research Dive Analysis

The Lidocaine segment accounted for a dominant market share in 2021. Lidocaine is a type of local anesthetic. It is used to anaesthetize or numb the surgical area during small surgical operations such as dental, oral, diagnostic, or other therapeutic treatments. It is also used to provide brief relief from other skin, eye, or ear irritations. The market is expanding due to its widespread use as a topical and injectable anesthetic.

Global Local Anesthesia Drugs Market, By Application

By application, the market has been divided into injectable and surface anesthetic. Among these, injectable segment had a dominant market share in 2021 and surface anesthetics is anticipated to have the fastest growth in the forecast time period.

Global Local Anesthesia Drugs Market Share, by Application, 2021

Source: Research Dive Analysis

The injectable segment accounted for a dominant market share in 2021. This is primarily because injectable anesthetics are widely used in a variety of surgical procedures. Injectable anesthetics are typically utilized for numbing rather than pain management during procedures. A local anesthetic injection may be required for dental work such as a root canal, skin biopsy, removal of a growth under the skin, and removal of a mole.

Global Local Anesthesia Drugs Market, Regional Insights

The local anesthesia drugs market was analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Global Local Anesthesia Drugs Market Size & Forecast, by Region, 2021-2031 ($ Million)

Source: Research Dive Analysis

The Local Anesthesia Drugs Market in North America to be the Most Dominant

The North America local anesthesia drugs market size accounted for a dominating market share in 2021. The region offers tremendous growth opportunity for growth of local anesthesia drugs market.  The market for local anesthesia drugs is expected to grow in North America because of a rise in the number of surgical procedures performed. The development of new anesthetic technologies for administration, as well as the rise in chronic diseases among the elderly, has fueled market expansion. The U.S. has the world's largest market share for anesthesia. Major players in the region with adequate investment in R&D for the manufacturing of revolutionary novel medications are a key component in the region's market growth. Also, established technologically advanced research and development centers and availability of experienced researchers to develop new drugs in the region is further anticipated to drive the market growth.

Competitive Scenario in Global Local Anesthesia Drugs Market

Investment and agreement are common strategies followed by major market players.

Source: Research Dive Analysis

The key players profiled in this report include Novartis AG, Aspen Pharmacare, Sagent Pharmaceuticals, Pacira Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi, Mylan N.V., GSK plc., AstraZeneca plc, and Hikma Pharmaceuticals plc.